Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:59011rdf:typepubmed:Citationlld:pubmed
pubmed-article:59011lifeskim:mentionsumls-concept:C0023418lld:lifeskim
pubmed-article:59011lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:59011lifeskim:mentionsumls-concept:C0682526lld:lifeskim
pubmed-article:59011lifeskim:mentionsumls-concept:C0332197lld:lifeskim
pubmed-article:59011lifeskim:mentionsumls-concept:C0486379lld:lifeskim
pubmed-article:59011pubmed:issue7974lld:pubmed
pubmed-article:59011pubmed:dateCreated1976-8-23lld:pubmed
pubmed-article:59011pubmed:abstractText60 leukaemia patients with acute mylogenous leukaemia, chronic myelocytic leukaemia, acute lymphatic leukaemia, and chronic lymphocytic leukaemia were tested for five specificities of the new B-lymphocyte alloantigenic system. Two specificities of the first B-cell locus were significantly lower in frequency than in B lymphocytes from 105 controls. B-cell group 1 was found in 18% of leukaemia patients vs. 48% of controls (p less than 0.025) and B-cell group 2 was found in 0% of leukaemia patients vs 23% of controls (p less than 0.025). Group 2 was also absent in 37 cultured lymphoblastoid lines. It is suggested that resistance to B-cell leukaemia and to Epstein-Barr virus transformation in vitro may be linked to a B-lymphocyte specificity on the first B-lymphocyte locus.lld:pubmed
pubmed-article:59011pubmed:languageenglld:pubmed
pubmed-article:59011pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:59011pubmed:citationSubsetAIMlld:pubmed
pubmed-article:59011pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:59011pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:59011pubmed:statusMEDLINElld:pubmed
pubmed-article:59011pubmed:monthJunlld:pubmed
pubmed-article:59011pubmed:issn0140-6736lld:pubmed
pubmed-article:59011pubmed:authorpubmed-author:TerasakiP IPIlld:pubmed
pubmed-article:59011pubmed:authorpubmed-author:PetersonPPlld:pubmed
pubmed-article:59011pubmed:authorpubmed-author:BillingR JRJlld:pubmed
pubmed-article:59011pubmed:authorpubmed-author:HonigRRlld:pubmed
pubmed-article:59011pubmed:issnTypePrintlld:pubmed
pubmed-article:59011pubmed:day26lld:pubmed
pubmed-article:59011pubmed:volume1lld:pubmed
pubmed-article:59011pubmed:ownerNLMlld:pubmed
pubmed-article:59011pubmed:authorsCompleteYlld:pubmed
pubmed-article:59011pubmed:pagination1365-7lld:pubmed
pubmed-article:59011pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:59011pubmed:meshHeadingpubmed-meshheading:59011-Hu...lld:pubmed
pubmed-article:59011pubmed:meshHeadingpubmed-meshheading:59011-Le...lld:pubmed
pubmed-article:59011pubmed:meshHeadingpubmed-meshheading:59011-Le...lld:pubmed
pubmed-article:59011pubmed:meshHeadingpubmed-meshheading:59011-Ch...lld:pubmed
pubmed-article:59011pubmed:meshHeadingpubmed-meshheading:59011-Le...lld:pubmed
pubmed-article:59011pubmed:meshHeadingpubmed-meshheading:59011-Ad...lld:pubmed
pubmed-article:59011pubmed:meshHeadingpubmed-meshheading:59011-Is...lld:pubmed
pubmed-article:59011pubmed:meshHeadingpubmed-meshheading:59011-Ge...lld:pubmed
pubmed-article:59011pubmed:meshHeadingpubmed-meshheading:59011-Ce...lld:pubmed
pubmed-article:59011pubmed:meshHeadingpubmed-meshheading:59011-Le...lld:pubmed
pubmed-article:59011pubmed:meshHeadingpubmed-meshheading:59011-Im...lld:pubmed
pubmed-article:59011pubmed:meshHeadingpubmed-meshheading:59011-Im...lld:pubmed
pubmed-article:59011pubmed:meshHeadingpubmed-meshheading:59011-B-...lld:pubmed
pubmed-article:59011pubmed:year1976lld:pubmed
pubmed-article:59011pubmed:articleTitleThe absence of B-cell antigen B2 from leukaemia cells and lymphoblastoid cell lines.lld:pubmed
pubmed-article:59011pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:59011pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:59011lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:59011lld:pubmed